Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program
Filetype[PDF-278.98 KB]


Details:
  • Supporting Files:
    No Additional Files
You May Also Like:
  1. Evidence to recommendations and GRADE for PCV13 use among immunocompetent adults ≥65 years old
    Personal Author:
    Matanock, Almea
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    February 28, 2019
    Series:
    ACIP meeting Pneumococcal Vaccines
    Description:
    Pneumococcal-5-Matanock-508.pdf
    File Type:
    Filetype[PDF - 1.03 MB]
  2. Pneumococcal vaccines
    Personal Author:
    Lee, Grace M.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    February 28, 2019
    Series:
    ACIP meeting Pneumococcal Vaccines
    Description:
    Pneumococcal-1-Lee-508.pdf
    File Type:
    Filetype[PDF - 420.50 KB]
  3. Advisory Committee on Immunization Practices (ACIP) summary report : February 27-28, 2019, Atlanta, Georgia
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA)
    Published Date:
    9/17/2019
    Series:
    ACIP meeting Minutes
    Description:
    Publication date from document properties.min-2019-02-508.pdf
    File Type:
    Filetype[PDF - 3.05 MB]
  4. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
    Personal Author:
    Matanock, Almea; Lee, Grace; Gierke, Ryan; Kobayashi, Miwako; Leidner, Andrew; Pilishvili, Tamara;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    November 22 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(46):1069-1075
    Description:
    Two pneumococcal vaccines are currently licensed for use in adults in the United States: a 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Pfizer, Inc.]) and a 23-valent pneumococcal polysaccharide vaccine (PPSV23 [Pneumovax 23, Merck an...
    File Type:
    Filetype[PDF - 392.16 KB]
  5. Advisory Committee on Immunization Practices (ACIP) summary report : June 26-27, 2019, Atlanta, Georgia
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2019 June 26-27 : Atlanta, GA)
    Published Date:
    11/4/19
    Series:
    ACIP meeting Minutes
    Description:
    Publication date from document properties.min-2019-06.pdf
    File Type:
    Filetype[PDF - 2.18 MB]